These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1762122)

  • 21. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Hyperparathyroidism.
    Fujiwara S
    J Radiat Res; 1991 Mar; 32 Suppl():245-8. PubMed ID: 1762112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Residual radioactivity in neutron-exposed objects and residual alpha radioactivity in black rain areas.
    Sakanoue M; Komura K; Tan K
    J Radiat Res; 1991 Mar; 32 Suppl():58-68. PubMed ID: 1762132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Biochemical genetics study.
    Satoh C
    J Radiat Res; 1991 Mar; 32 Suppl():378-84. PubMed ID: 1762126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
    Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M
    Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Brain damage among the prenatally exposed.
    Otake M; Schull WJ; Yoshimaru H
    J Radiat Res; 1991 Mar; 32 Suppl():249-64. PubMed ID: 1762113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid diseases in atomic bomb survivors exposed in utero.
    Imaizumi M; Ashizawa K; Neriishi K; Akahoshi M; Nakashima E; Usa T; Tominaga T; Hida A; Sera N; Soda M; Fujiwara S; Yamada M; Maeda R; Nagataki S; Eguchi K
    J Clin Endocrinol Metab; 2008 May; 93(5):1641-8. PubMed ID: 18319305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Future perspective of radiobiological studies.
    Akiyama M; Nakamura N
    J Radiat Res; 1991 Mar; 32 Suppl():394. PubMed ID: 1762128
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
    Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
    Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed effects of low-dose radiation on cellular immunity in atomic bomb survivors residing in the United States.
    Bloom ET; Akiyama M; Kusunoki Y; Makinodan T
    Health Phys; 1987 May; 52(5):585-91. PubMed ID: 3570796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
    Brenner DJ
    Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of five anthropometric measurements at age 18 to radiation dose among atomic bomb survivors exposed in utero.
    Nakashima E
    Radiat Res; 1994 Apr; 138(1):121-6. PubMed ID: 8146291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Future research in epidemiology and statistics at RERF.
    Mabuchi K; Preston DL
    J Radiat Res; 1991 Mar; 32 Suppl():375-7. PubMed ID: 1762125
    [No Abstract]   [Full Text] [Related]  

  • 36. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors.
    J Radiat Res; 1991 Mar; 32 Suppl():1-412. PubMed ID: 1762094
    [No Abstract]   [Full Text] [Related]  

  • 37. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Thyroid cancer: reports up to date and a review.
    Takeichi N; Ezaki H; Dohi K
    J Radiat Res; 1991 Mar; 32 Suppl():180-8. PubMed ID: 1762104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A close correlation between electron spin resonance (ESR) dosimetry from tooth enamel and cytogenetic dosimetry from lymphocytes of Hiroshima atomic-bomb survivors.
    Nakamura N; Miyazawa C; Sawada S; Akiyama M; Awa AA
    Int J Radiat Biol; 1998 Jun; 73(6):619-27. PubMed ID: 9690680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality among the offspring (F1) of atomic bomb survivors, 1946-85.
    Yoshimoto Y; Schull WJ; Kato H; Neel JV
    J Radiat Res; 1991 Dec; 32(4):327-51. PubMed ID: 1817186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Chromosome abnormality in early entrants.
    Kamada N
    J Radiat Res; 1991 Mar; 32 Suppl():275-7. PubMed ID: 1762115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.